Q's top three insider shareholders as of May 30, 2026 are Paul Rivard (Chief Legal Officer, 400.00K shares), Chelsea Sierra Voss (Director, 239.90K shares), Bruce Bernstein (Director, 25.00K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Gary M Rauch | - | 12,500 | 0 | 14 Nov, 2025 |
| Bruce Bernstein | - | 25,000 | 0 | 14 Nov, 2025 |
| Paul Rivard | Chief Legal Officer | 400,000 | 0 | 24 Aug, 2023 |
| Mitchell Glass | Director, Chief Medical Off. | 12,500 | 0 | 17 Nov, 2025 |
| Stephen Friscia | - | 25,000 | 0 | 14 Nov, 2025 |
| Chelsea Sierra Voss | - | 239,900 | 0 | 30 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 13 Apr, 2026 | Chelsea Sierra Voss | Employee Stock Option (Right to Buy) | A | 50,000 | $0.00 | 50,000 | D | A |
| 13 Apr, 2026 | Mitchell Glass | Employee Stock Option (Right to Buy) | A | 50,000 | $0.00 | 50,000 | D | A |
| 13 Apr, 2026 | Bruce Bernstein | Employee Stock Option (Right to Buy) | A | 50,000 | $0.00 | 50,000 | D | A |
| 13 Apr, 2026 | Billy Joe White | Employee Stock Option (Right to Buy) | A | 50,000 | $0.00 | 50,000 | D | A |
| 16 Jan, 2026 | Chelsea Sierra Voss | Common stock | A | 212,500 | $0.00 | 214,900 | D | A |
| 16 Jan, 2026 | Chelsea Sierra Voss | Common stock | A | 25,000 | $0.00 | 239,900 | D | A |
| 16 Jan, 2026 | Chelsea Sierra Voss | Employee Stock Option (Right to Buy) | A | 212,500 | $0.00 | 212,500 | D | A |
| 04 Sep, 2025 | Biotech, Inc. Pharmacyte | Series H Convertible Preferred Stock | A | 889,865 | - | 889,865 | D | P |
| 14 Nov, 2025 | Biotech, Inc. Pharmacyte | Warrants | A | 889,865 | - | 889,865 | D | P |
| 14 Nov, 2025 | Mitchell Glass | Common stock | A | 11,420 | $0.00 | 12,500 | D | A |
| 14 Nov, 2025 | Stephen Friscia | Common stock | A | 22,839 | $0.00 | 25,000 | D | A |
| 14 Nov, 2025 | Gary M Rauch | Common stock | A | 11,420 | $0.00 | 12,500 | D | A |
| 14 Nov, 2025 | Bruce Bernstein | Common stock | A | 25,000 | $0.00 | 25,000 | D | A |
| 03 Oct, 2025 | Gary M Rauch | Common stock | A | 1,080 | $0.00 | 1,080 | D | A |
| 03 Oct, 2025 | Stephen Friscia | Common stock | A | 2,161 | $0.00 | 2,161 | D | A |
| 03 Oct, 2025 | Mitchell Glass | Common stock | A | 1,080 | $0.00 | 1,080 | D | A |
| 17 Apr, 2025 | Gary M Rauch | Employee Stock Option (Right to Buy) | A | 75,000 | $0.00 | 75,000 | D | A |
| 17 Apr, 2025 | Ian Rhodes | Employee Stock Option (Right to Buy) | A | 25,000 | $0.00 | 25,000 | D | A |
| 17 Apr, 2025 | Mitchell Glass | Employee Stock Option (Right to Buy) | A | 125,000 | $0.00 | 125,000 | D | A |
| 24 Aug, 2023 | Paul Rivard | Common stock | A | 150,000 | $1.11 | 400,000 | D | P |